UBS O'Connor’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Sell |
56,810
-1,912
| -3% | -$63.6K | 0.1% | 151 |
|
|
2025
Q1 | $1.72M | Buy |
58,722
+15,392
| +36% | +$451K | 0.05% | 128 |
|
|
2024
Q4 | $1.42M | Buy |
43,330
+22,243
| +105% | +$731K | 0.04% | 193 |
|
|
2024
Q3 | $937K | Sell |
21,087
-8,926
| -30% | -$397K | 0.02% | 282 |
|
|
2024
Q2 | $1.29M | Sell |
30,013
-49,893
| -62% | -$2.15M | 0.04% | 258 |
|
|
2024
Q1 | $2.34M | Sell |
79,906
-46,913
| -37% | -$1.37M | 0.07% | 151 |
|
|
2023
Q4 | $2.82M | Buy |
126,819
+21,598
| +21% | +$481K | 0.09% | 125 |
|
|
2023
Q3 | $2.6M | Buy |
105,221
+39,000
| +59% | +$965K | 0.05% | 192 |
|
|
2023
Q2 | $1.88M | Buy |
66,221
+13,721
| +26% | +$389K | 0.04% | 306 |
|
|
2023
Q1 | $1.21M | Buy |
+52,500
| New | +$1.21M | 0.03% | 382 |
|
|
2016
Q2 | – | Sell |
-8,076
| Closed | -$328K | – | 366 |
|
|
2016
Q1 | $328K | Buy |
+8,076
| New | +$328K | 0.01% | 359 |
|
|
2013
Q4 | – | Sell |
-20,000
| Closed | -$559K | – | 351 |
|
|
2013
Q3 | $559K | Buy |
+20,000
| New | +$559K | 0.01% | 316 |
|